HCAI Tier 1 Targets Mari Morgan, WHAIP

Slides:



Advertisements
Similar presentations
Quality improvement guide: prevention and control of healthcare-associated infections Learning and development resource for board members 2012 NICE public.
Advertisements

Headache Services in Wales in Neurology and other disciplines
Susan Harris ( ) Welsh Healthcare Associated Infection Programme Welsh Healthcare Associated Infection Programme: Reporting.
Dr Richard Hain Lead Clinician, Welsh PPM Managed Clinical Network Sugar Implementation Children and Transition Stakeholders’ Conference 29 th September.
The Welsh context – Smoking cessation in Wales and current targets Sue Bowker Tobacco Policy Welsh Government
Information for Action Point Prevalence Survey of Healthcare associated infection and antimicrobial use 26 th June 2012 Dafydd Williams.
PENNINE ACUTE HOSPITALS NHS TRUST HCAI RECOVERY Vic Crumbleholme/Louise Dickinson Associate Director of Nursing/Nurse Consultant Prevention & Control of.
Problematic and injecting drug use – findings from the Harm Reduction Database (HRD) Presenter: Josie Smith, Health Protection, PHW.
Insert name of presentation on Master Slide HCAI Charts HCAI Information for Action, November 2010 Presenter: Mari Morgan, Wendy Harrison.
The ‘impossible dream’ Implementing a No Smoking Policy on hospital grounds - Why preventing smoking in the workplace requires more than just policy Trina.
FINANCE TRAINING INTRODUCTION AND SECTION 1: NHS FUNDING IN WALES 1.
Insert name of presentation on Master Slide Transforming Maternity Services Mini-Collaborative Introductory WebEx Call Thursday 4 th May 2011 Call Facilitator.
Implementation of a Quality Management System across a Network of Microbiology Laboratories Presenter: Anne Thomas Health Protection Quality Improvement.
HCAI Information for ACtion 2010
Wales Primary Care COPD Audit
Lung Cancer in Wales January 2015
Why Do We Need WCCIS Policy Drivers
Tackling Urinary Tract Infection: part of the Paradigm Shift in HCAI Management in Hywel Dda UHB Dr Mike Simmons.
Making the most of your culture surveys
Improving Infection Prevention & Control Practices
Collection of influenza immunisation uptake data from General Practices Simon Cottrell, Public Health Wales Communicable Disease Surveillance Centre and.
Telehealth & Innovation
Tackling antimicrobial resistance and improving antibiotic prescribing
Cardiac Diagnostic Waits National Cardiac Services Review Day
Presented by Julie Rowles / Amanda Edwards
Welcome Dr. Eleri Davies, Faculty Lead HCAI.
Cardiff and Vale University HB trends in routine childhood immunisations Quarter 2 Source: Public Health Wales quarterly COVER reports, correct.
Smoking Cessation Service for People with Mental Illness
How to use this slide deck: 1. Fill in business information
National COPD Audit Programme
Child Measurement Programme for Wales maps 2015/16
Culture surveys in 1000 Lives Plus
Unscheduled Care Analysis
Discovery in Action: Case Study
Cancer in Wales Population incidence of stage at diagnosis Official statistics Published 09:30 hrs 24 November
2018 NM Community Survey Data Entry Training
Sexual Health and Wellbeing for Wales
Child Measurement Programme for Wales report 2016/17
Welcome / Croeso Dr. Eleri Davies
December 2011 Measuring inequalities: Trends in mortality and life expectancy in Abertawe Bro Morgannwg Measuring lifestyle: methods and limitations.
> 24,000 people waiting > 270,000 days waited in each speciality
Are we Doing to Many Procedures? (Example Tonsillectomy)
Information for Action HCAI Surveillance Data: Laboratory data 15th July 2015 Mari Morgan WHAIP Surveillance.
Clinical Governance Practice Self Assessment Tool (CGPSAT) update
April 2012 Wider Determinants of Health: Abertawe Bro Morgannwg University Health Board Public Health Wales Observatory Public Health Wales Observatory.
Title EECS Mid-Semester Presentation
ABMU Antibiotic Audits An Update
Matching the Best in the World
HIV and STI trends in Wales: 2017
Improving wound management through inter-professional collaboration.
Tuberculosis in Wales Annual Report 2018 Data to the end of 2017
National COPD Audit Programme
To Dip Or Not To Dip – Improving the management of Urinary Tract Infection in older people Improving Patient Safety & Care 6th Feb 2019 Continuous Learning,
Child Measurement Programme for Wales Report 2013/14
Sharing information to understand the shared issues
The Public Health Wales website
Discovery in Action: Case Study
Unscheduled Care Analysis
Ambitions and Trajectories
Prudent healthcare in NHS Wales
10th December 2013 Person-Centred Care.
Improved Register Data Matching and its Impact on Survey Population Estimates Steve Vale Office for National Statistics, UK.
Child Measurement Programme for Wales report 2017/18
Implementing Interventions – Success from 1000 Lives Campaign
Cardiff and Vale UHB Dr Graham Shortland
UK Renal Registry 14th Annual Report
Unscheduled Care Analysis
Are we Doing to Many Procedures? (Example Tonsillectomy)
Tuberculosis in Wales Annual Report 2017 Data to the end of 2016
Discovery in Action: Case Study
Presentation transcript:

HCAI Tier 1 Targets Mari Morgan, WHAIP 6th November 2014 HCAI Tier 1 Targets Mari Morgan, WHAIP Insert name of presentation on Master Slide

HCAI Tier 1 Targets For 01/04/2014 to 30/09/2015, the major HBs in Wales should have rates of no more than the following: C. difficile – 31 per 100,000 resident population MRSA bacteraemia – 2.6 per 100,000 resident population Major HBs – Powys and Velindre excluded HCAI Tier 1 Targets

HCAI Tier 1 Targets - Background Wales rates 2012/13: C. difficile: 63 per 100,000 population (33 – 92) MRSA bacteraemia: 5.2 per 100,000 population (4 - 7) Aim to reduce Wales rate by 50% and reduce variability between HBs. HCAI Tier 1 Targets

HCAI Tier 1 Targets - Background Rates of total C. difficile per 100,000 population in UK countries by financial year Age standardisation HCAI Tier 1 Targets

HCAI Tier 1 Targets - Background Rates of MRSA bacteraemia per 100,000 population in UK countries by financial year HCAI Tier 1 Targets

HCAI Tier 1 Targets – How are they calculated? Numerator = Total C. difficile (age 2y+)/MRSA bacteraemia diagnosed in HB (IP, OP, GP) with spec dates from 01/04/14 – 30/09/15 Denominator = HB resident population * 1.5 HCAI Tier 1 Targets

HCAI Tier 1 Targets – How are they calculated? Each HB provided with max no of C. difficile/ MRSA bacteraemia in the 18m period that would still allow them to achieve the target rates, using 2012 mid year population estimates. Health Board C. difficile (2013/14) Abertawe Bro Morgannwg University 245 (219) Aneurin Bevan University 273 (383) Betsi Cadwaladr University 326 (447) Cardiff & Vale University 225 (260) Cwm Taf University 139 (82) Hywel Dda University 181 (148) MRSA bacteraemia (2013/14) 21 (29) 23 (22) 27 (47) 19 (31) 12 (13) 15 (20) HCAI Tier 1 Targets

HCAI Tier 1 Targets – How are they monitored? Weekly downloads from Datastore of C. difficile and blood culture test results Cleaning, deduplication Monthly dashboard produced HBs and WG, published on HB websites, Wales on PHW website Remove QA samples, aspirates in blood culture bottles etc Cdiff are deduplicated based on 28 days, MRSA bacteraemia – 14 days Dashboard also includes MSSA results – not part of target HCAI Tier 1 Targets

HCAI Tier 1 Targets – How are they monitored? Monthly Update Tab All data for the current financial year is provisional. Final numbers for the year are available around June/July for the previous financial year. Rates per 1000 admissions or per 100,000 population. Select box at the top – you can choose entire HB or one of the major acute hosps within HB or Wales and select organisms – Cdiff, MRSA or MSSA bacteraemia. Wales HCAI Surveillance Review

HCAI Tier 1 Targets – How are they monitored?

HCAI Tier 1 Targets – How are they monitored? Target Monitoring Tab

HCAI Tier 1 Targets – How are we doing so far? 1/3 into target time period No HBs currently on trajectory to achieve C. difficile or MRSA bacteraemia target (using average monthly numbers) Wales rates for Apr-Sep 14: C. difficile = 44 (HBs:38 - 56) MRSA bacteraemia = 5.1 (HBs: 3.4-8.8) These were the rates provided in the last monthly dashboard. Next one will be issued tomorrow – data for Apr – Sep will be updated. HCAI Tier 1 Targets

HCAI Tier 1 Targets – How are we doing so far? Because we are not on trajectory now, doesn’t mean that the target won’t be achieved). The rate is like an average speed check; if we go faster than 50 at the beginning, we need to go slower than 50 later on to make it 50 overall. Everyone’s numbers are too high at the beginning of the surveillance period which means they will need to be much lower later on in the target period and will still achieve target HCAI Tier 1 Targets

HCAI Tier 1 Targets – How are we doing so far? C. difficile: 24% fewer cases compared to Apr – Sep 13 MRSA bacteraemia: 1% fewer cases compared to Apr – Sep 13 C. difficile MRSA bacteraemia For some HBs it is too late for the MRSA bacteraemia target. Maybe that they can demonstrate that for the last 6 months of the target period they achieved the required rate. HCAI Tier 1 Targets

HCAI Tier 1 Targets – What would success look like?